Data is not available at this time.
Wanxiang Doneed operates as a specialized agricultural biotechnology company focused on the research, development, production, and commercialization of hybrid corn seeds primarily within the Chinese market. The company leverages advanced breeding techniques and genetic research to develop high-yield, disease-resistant seed varieties that address the specific climatic and soil conditions across China's diverse agricultural regions. Its core revenue model centers on selling proprietary seed varieties to farmers and agricultural distributors, with additional income from licensing agreements and research collaborations. Operating in the consumer defensive sector, Wanxiang Doneed occupies a strategic position in China's food security ecosystem, serving as a critical link between agricultural innovation and farm productivity. The company maintains a focused regional presence, concentrating its operations predominantly in northern China where corn cultivation is most prevalent, while competing with both domestic seed producers and multinational agricultural corporations in a market increasingly prioritizing yield optimization and sustainability.
The company generated CNY 342.8 million in revenue with net income of CNY 52.6 million, demonstrating solid profitability with a net margin of approximately 15.4%. However, operating cash flow was negative at CNY -73.1 million, indicating potential working capital challenges or timing differences in receivables collection that warrant monitoring despite strong bottom-line performance.
Wanxiang Doneed exhibits respectable earnings power with diluted EPS of CNY 0.18, supported by efficient operations in its specialized niche. The company maintains minimal capital expenditures (CNY -4.7 million), suggesting a capital-light business model that focuses on research and development rather than heavy infrastructure investment, though negative operating cash flow raises questions about sustainable cash generation.
The company maintains an exceptionally strong balance sheet with CNY 346.7 million in cash and equivalents and zero debt, providing significant financial flexibility and resilience. This conservative financial structure positions Wanxiang Doneed to weather industry volatility and potentially pursue strategic investments without leverage constraints.
The company demonstrates a shareholder-friendly approach with a dividend per share of CNY 0.15, representing a substantial payout ratio relative to earnings. This dividend policy, combined with a debt-free balance sheet, suggests management's confidence in sustainable cash generation despite the recent negative operating cash flow position.
With a market capitalization of approximately CNY 2.7 billion, the company trades at a P/E ratio around 51x based on current earnings, indicating market expectations for future growth in China's agricultural technology sector. The low beta of 0.541 suggests the stock is perceived as relatively defensive compared to the broader market.
Wanxiang Doneed's primary advantages include its specialized expertise in hybrid corn seeds, strong balance sheet, and strategic positioning in China's agricultural sector. The outlook depends on successful research outcomes, adoption of new seed varieties, and navigating competitive pressures while maintaining profitability in a essential but cyclical industry.
Company financial statementsMarket data providersExchange disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |